Asthma and COPD patients in the UK are set to receive faster, community-based care under a £10 million NHS initiative, ...

Escalating to extrafine single-inhaler triple therapy significantly reduces exacerbations in patients with moderate to severe COPD.

Zydus Lifesciences Limited, an innovation-led life-sciences company with an international presence, has launched Aerolife ...

Asthma and chronic obstructive pulmonary disease patients will receive better care closer to home under a landmark £10million partnership Care for ...

Patients with COPD and heart failure treated with SGLT-2 inhibitors experienced higher rates of volume depletion and adverse renal events. Chronic obstructive pulmonary disease (COPD) reduces the ...

Individuals with chronic obstructive pulmonary disease (COPD) with coexisting obstructive sleep apnea (OSAS) have greater ...

Reinventing pulmonary care medically improves early diagnosis and interdisciplinary management for complex patients with COPD and co-morbidities.

Patients living with asthma and chronic obstructive pulmonary disease (COPD) will receive faster, better and more personalised care under a landmark new programme to tackle one of the leading causes ...

Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Cl ...

I've recently been diagnosed with COPD. I find it difficult to get around due to my breathing. Is there anything I can do to reduce my symptoms? Dr Philippa Kaye answers: Chronic obstructive pulmonary ...

Chronic obstructive pulmonary disease (COPD) is known for causing breathing difficulties and limiting everyday activities. Obstructive sleep apnea syndrome (OSAS), on the other hand, is usually ...